• 1
    Brennan M, Alektiar KM, Maki RG. Soft tissue sarcoma. In: DeVitaVT, HellmannS, RosenbergSA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins, 2001: 18411891.
  • 2
    Eilber FC, Eilber FR. Soft tissue sarcoma. In: CameronJL, editor. Current surgical therapy (7th edition). St. Louis: CV Mosby, 2001: 12131218.
  • 3
    Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study on 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996; 14: 869877.
  • 4
    Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996; 14: 16791689.
  • 5
    Eilber FC, Rosen G, Nelson S, et al. High grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003; 237: 218226.
  • 6
    Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791796.
  • 7
    Graefen M, Karakiewicz PI, Cagiannos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol. 2002; 20: 951956.
  • 8
    Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999; 130: 515524.
  • 9
    Hajdu SI, Shiu MH, Brennan MF. The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988; 12: 326331.
  • 10
    GreeneFL, PageDL, FlemingID, et al., editors. AJCC cancer staging manual (6th edition). New York: Springer-Verlag, 2002.
  • 11
    Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001; 19: 12381247.
  • 12
    Eilber FC, Rosen G, Eckardt J, et al. Treatment induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 2001; 19: 32033209.
  • 13
    Eilber FC, Eilber FR, Eckardt J, et al. Ifosfamide-based chemotherapy is associated with improved survival in patients with primary extremity synovial sarcoma [abstract]. Proc Am Soc Clin Oncol. 2004; 23: 818.
  • 14
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 15
    Greenwood M. Reports on public health and medical subjects. The errors of sampling of the survivorship tables. London: H. M. Stationery Office, 1926.
  • 16
    Harrell FE Jr., Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982; 247: 25432546.
  • 17
    Harrell FE Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag, 2001.
  • 18
    Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999; 175: 14991507.
  • 19
    Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1999; 350: 16471654.
  • 20
    Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93: 358366.